Pharmafile Logo
Pharmafocus logo
Advanced Search
fda2outsideweb

AZ’s Farxiga becomes first FDA-approved SGLT2 inhibitor for heart failure with reduced ejection fraction

May 6, 2020
Research and Development, Sales and Marketing AstraZeneca, FDA, farxiga, heart failure

The FDA has moved to approve an oral tablet formulation of AstraZeneca’s Farxiga (dapagliflozin) to reduce the risk of cardiovascular …

News
partnership

Portola Pharmaceuticals to merge with Alexion in $1.41bn cash deal

May 6, 2020
Research and Development, Sales and Marketing Alexion, Portola Pharmaceuticals, pharma

Alexion has announced it is to acquire Boston-based blood disorder specialist Portola Pharmaceuticals in a transaction to the value of …

News
coroanrvisu_cdc

Pharmafile.com’s weekly COVID-19 news round-up

May 6, 2020
Research and Development COVID-19, coronavirus

Vaccines and treatments for COVID-19 continue to dominate the news, as two studies reveal “positive” data for Gilead’s remdesivir in …

News
trumpppppp

Ousted chief of BARDA says Trump administration ignored COVID-19 warnings

May 6, 2020
Research and Development BARDA, COVID-19, chloroquine, coronavirus, hydroxychloroquine

Ousted Director of the Biomedical Advanced Research and Development Authority (BARDA), Dr Rick Bright, alleges the Trump administration ignored warnings …

News
jonathanfreve

Jonathan Freve joins Galecto as Chief Financial Officer

May 5, 2020
Manufacturing and Production

The biotech company Galecto Inc have appointed Jonathan Freve as its Chief Financial Officer, and in his role he will …

Appointment
france-3370174_1280

First French case of COVID-19 occurred in December, a month earlier than previously thought

May 5, 2020
Manufacturing and Production COVID-19, coronavirus

A French patient who suffered from pneumonia in December actually had COVID-19, it has been revealed. Dr Yves Cohen, the …

News
Malaria treatment in Angola

Scientists in Kenya discover microbe that could stop transmission of malaria

May 5, 2020
Manufacturing and Production malaria, mosquitoes

Researchers studying malaria in Kenya have discovered a microbe that blocks transmission of malaria from mosquitoes which could pave the …

News
s300_yellow-card-govuk960

MHRA launches new pharmacovigilance reporting platform for COVID-19 treatments

May 5, 2020
Manufacturing and Production, Research and Development COVID-19, MHRA, UK, coronavirus, pharma

A new online reporting site has been launched by the Medicines and Healthcare products Regulatory Agency’s (MHRA) to track potential …

News
isle_of_wight

UK contact-tracing app being tested on the Isle of Wight

May 5, 2020
Manufacturing and Production COVID-19, coronavirus

The NHS’s coronavirus contract tracing app has been published to Apple and Google’s app stores with council staff and healthcare …

News
shutter

Sanofi and Regeneron’s Libtayo shows durable responses in world’s most common skin cancer

May 5, 2020
Manufacturing and Production, Research and Development Cancer, Libtayo, Regeneron, Sanofi

Sanofi and Regeneron’s have lifted the lid on new topline data on their PD-1 inhibitor Libtayo (cemiplimab) in patients with …

News
kim_stratton_orphazyme

Working Life Interview: Kim Stratton, CEO, Orphazyme

May 4, 2020
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Interview, Orphazyme, Working Life

“Every professional faces challenges. As a woman in industry, particularly in leadership, it adds another dimension to those challenges in …

Feature
flu_shot_2019

Lonza and Moderna enter agreement to mass produce coronavirus vaccine

May 4, 2020
Sales and Marketing COVID-19, coronavirus

Lonza Group AG and Moderna Inc have entered a deal to develop 1 billion doses of coronavirus vaccines a year. …

News
gilead-sciences

FDA approves emergency use of Gilead’s remdesivir for hospitalised COVID-19 patients

May 4, 2020
Sales and Marketing COVID-19, FDA, Gilead, coronavirus, remdesivir

Gilead’s antiviral therapy remdesivir has shown tentatively promising efficacy in the race to find an effective treatment for COVID-19, one …

News
trumpy

Trump vows to reduce America’s reliance on foreign drug imports

May 4, 2020
Sales and Marketing COVID-19, coronavirus

President Donald Trump has vowed to cut the US’s reliance on foreign drugs, singling out China and Ireland as countries …

News
korean_1

UK testing experimental treatment for use in COVID-19 patients

May 4, 2020
Sales and Marketing COVID-19, coronavirus, coronavirus treatment

British scientists are testing an experimental drug to help some of society’s most vulnerable fight off the COVID-19 coronavirus.

News
mike

Mike Pompeo says there is evidence COVID-19 was made in a lab, despite US intelligence saying it occurred naturally

May 4, 2020
Sales and Marketing COVID-19, Wuhan Institute of virology, coronavirus, lab, pandemic

US Secretary of State Mike Pompeo claimed that there is evidence the COVID-19 coronavirus was created in a lab, despite …

News
nhssss

NHS sets out plans to deal with the second phase of the pandemic

May 1, 2020
Medical Communications COVID-19, coronavirus

The NHS has set out plans to step up its non-COVID-19 services over the next six weeks. A letter from …

News
800px-european_commission_flags

Positive CHMP opinion for BMS and Acceleron’s Reblozyl in transfusion-dependent anaemia sub-populations

May 1, 2020
Medical Communications, Sales and Marketing Acceleron, Bristol-Myers Squibb, EU, Reblozyl

Bristol Myers Squibb and Acceleron Pharma’s Reblozyl (luspatercept) has secured a positivr opinion from the European Medicines Agency’s Committee for Medicinal …

News
facemask

COVID-19 pandemic likely to last two years, study says

May 1, 2020
Medical Communications COVID-19, coronavirus, pandemic

The coronavirus pandemic is likely to last as long as two years and will not be properly controlled until two-thirds …

News

Vertex’s Kalydeco seizes EU CHMP recommendation for Kalydeco in R117H+ cystic fibrosis

May 1, 2020
Medical Communications, Sales and Marketing Europe, Kalydeco, Vertex, cystic fibrosis

The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has given its recommendation for the approval …

News
The Gateway to Local Adoption Series

Latest content

Alto Neuroscience announces new patent for depression treatment

January 15, 2026

Arkin Capital closes $100m fund for pre-clinical and early clinical-stage biotech

January 15, 2026

Bio-Sourcing and Zerion Pharma receive 1.3m euros in funding for joint breast cancer project

January 14, 2026

Biocartis announces breast cancer research collaboration with US Mayo Clinic

January 14, 2026

Blue Earth announces first UK patient received prostate cancer injection

January 13, 2026